The Anti-Inflammatory Effects of Intermittent Fasting and Protein Pacing

Chronic low-grade inflammation is increasingly recognised as a root driver of modern disease. It’s linked to cardiovascular disease, type 2 diabetes, Alzheimer’s, certain cancers, and the general process of aging itself. Unlike acute inflammation (a healthy response to injury), chronic inflammation simmers quietly for years, damaging tissues from the inside.

The key inflammatory markers

Three biomarkers are commonly used to measure systemic inflammation, and all three are reduced by IF-P:

• C-reactive protein (CRP): Produced by the liver in response to inflammation. Elevated CRP is one of the strongest independent predictors of cardiovascular events. Levels above 3 mg/L indicate high cardiovascular risk.
• Interleukin-6 (IL-6): A pro-inflammatory cytokine that drives the acute phase response. Chronically elevated IL-6 is associated with insulin resistance, depression, and accelerated aging.
• Tumour necrosis factor alpha (TNF-α):A master regulator of inflammatory signalling. Elevated TNF-α promotes insulin resistance, muscle wasting, and joint inflammation.

How fasting reduces inflammation

Fasting triggers several anti-inflammatory pathways:

• Autophagy:During extended fasting periods, cells activate autophagy — a self-cleaning process that digests damaged proteins, dysfunctional mitochondria, and cellular debris. This “cellular housekeeping” removes many of the triggers that cause inflammatory signalling.
• Reduced visceral fat:Visceral adipose tissue is essentially an endocrine organ that actively secretes inflammatory cytokines (IL-6, TNF-α). When IF-P reduces visceral fat by 33%, it physically removes a major source of inflammatory signalling from the body.
• Monocyte suppression: A 2019 study in Cell found that fasting reduces the number of circulating monocytes (a type of white blood cell) and suppresses their inflammatory activity, without compromising immune defence against infection.
• Ketone body signalling:Beta-hydroxybutyrate (BHB), the primary ketone produced during fasting, directly inhibits the NLRP3 inflammasome — a key component of the inflammatory cascade. BHB essentially acts as a molecular “off switch” for inflammation.

The protein pacing contribution

Protein pacing adds to the anti-inflammatory effect through several mechanisms. The 35/35/30 macro distribution ensures adequate omega-3 fatty acids from protein sources (salmon, eggs, nuts) and fibre from complex carbohydrates — both of which support anti-inflammatory pathways.

Additionally, maintaining lean mass through protein pacing matters because skeletal muscle itself produces anti-inflammatory myokines during contraction. More muscle means a larger anti-inflammatory reservoir, creating a virtuous cycle: less inflammation allows better training, which builds more muscle, which produces more anti-inflammatory signals.

The clinical evidence

The 2023 Obesitytrial showed that IF-P participants had significantly reduced inflammatory markers compared to the standard caloric restriction group. This is notable because both groups lost weight — but weight loss alone wasn’t enough to match the anti-inflammatory effects of the IF-P combination.

This suggests that the fasting and protein pacing components provide anti-inflammatory benefits beyond what can be explained by weight loss alone. The meal timing and macro distribution appear to be independent anti-inflammatory interventions.

What you’ll notice

Reduced inflammation manifests in tangible ways: less joint stiffness, better recovery after exercise, improved skin clarity, more stable energy levels, and better sleep quality. These changes typically become noticeable within 2–4 weeks of starting an IF-P protocol, well before the full 8-week results measured in clinical trials.